Replies to post #540 on Tribute Pharmaceuticals Canada Inc. (fka TBUFF)

[gpg]

As I've had time to analyze today's PR a little more, it seems to me expected 4rth quarter revenue of $5.2M is a little bit of a let down. 3rd quarter revenue was $3.8M. The 10/2 transaction which added licenses for drugs that had a 12 month trailing revenue (see company presentation on their website) of $10M should have added at least $2.5M to the company's 4rth quarter revenue. Am I missing something here or is this revenue number a disappointment? TIA